Last Posted: Feb 13, 2020
- An 8‑gene signature predicts the prognosis of cervical cancer following radiotherapy.
Xie Fei et al. Molecular medicine reports 2019 Oct 20(4) 2990-3002 - An Integrated Model Based on a Six-Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma.
Li Wenli et al. Frontiers in genetics 2019 101323 - Young-Onset Colon Cancer and Recurrence Risk By Gene Expression.
Chang George J et al. Journal of the National Cancer Institute 2020 Feb - A 4-gene signature from histologically normal surgical margins predicts local recurrence in patients with oral carcinoma: clinical validation.
Reis Patricia P et al. Scientific reports 2020 Feb 10(1) 1713 - Prognostic Correlation of Autophagy-Related Gene Expression-Based Risk Signature in Patients with Glioblastoma.
Wang Qiang-Wei et al. OncoTargets and therapy 2020 1395-107 - Precision oncotherapy based on liquid biopsies in multidisciplinary treatment of unresectable recurrent rectal cancer: a retrospective cohort study.
Guadagni Stefano et al. Journal of cancer research and clinical oncology 2020 Jan 146(1) 205-219 - A robust two-gene signature for glioblastoma survival prediction.
Pan Yuhualei et al. Journal of cellular biochemistry 2020 Jan - Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
Zhang Fa-Peng et al. World journal of gastroenterology 2020 Jan 26(2) 134-153 - Development and validation of a gene expression test to identify hard-to-heal chronic venous leg ulcers.
Bosanquet D C et al. The British journal of surgery 2019 106(8) 1035-1042 - A 21‑gene Support Vector Machine classifier and a 10‑gene risk score system constructed for patients with gastric cancer.
Jiang Hui et al. Molecular medicine reports 2019 Nov
.jpeg)
No hay comentarios:
Publicar un comentario